RNS Number : 6348L Renalytix PLC 14 September 2021 This announcement contains inside information Renalytix plc (" Renalytix " or the " Company ") Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX TM Enabled Health Care Model Targeted testing run rate of 300 diabetic
RNS Number : 6078L Renalytix PLC 13 September 2021 Renalytix plc (" Renalytix " or the " Company ") Issue of shares under the 2020 employee share purchase plan and Total Voting Rights NEW YORK and SALT LAKE CITY , September 13 2021 - Renalytix Plc (NASDAQ: RNLX) (LSE: RENX)
RNS Number : 8886K Renalytix PLC 06 September 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 6 September 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 3,000
RNS Number : 6161K Renalytix PLC 03 September 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix to present at the 2021 Wells Fargo Virtual Healthcare Conference NEW YORK and SALT LAKE CITY , September 3, 2021 -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces that the
RNS Number : 2789K Renalytix PLC 31 August 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 2775K Renalytix PLC 31 August 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered
RNS Number : 2097K Renalytix PLC 31 August 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered
RNS Number : 1082K Renalytix PLC 31 August 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Appoints Daniel J. Levangie to its Board of Directors Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation
RNS Number : 8163J Renalytix PLC 26 August 2021 Renalytix plc (" Renalytix " or the " Company ") Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX TM Testing at Primary Care Level Peer reviewed publication in Journal of Medical Economics supports payer coverage for
RNS Number : 6311I Renalytix PLC 13 August 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
